Pathological complete response to neoadjuvant therapy with serplulimab and chemotherapy in stage IIIB small cell lung cancer: a case report and literature review
Ting Mei, Ting Wang, Chuanfen Lei, Dan Jiang, Qinghua Zhou · 2024
Read Pathological complete response to neoadjuvant therapy with serplulimab and chemotherapy in stage IIIB small cell lung cancer: a case report and literature review by Ting Mei, Ting Wang, Chuanfen Lei, Dan Jiang, Qinghua Zhou (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10830647.txt.
Description
Ting Mei and four co-authors report a lung cancer case with a full clear out in a paper whose head dates it to 2023. The patient had small cell lung cancer at a stage where the disease had spread in the chest but not past it. This cancer type rarely gets surgery, and the gains of drug plus immune care before surgery were unknown for it.
The patient took five rounds of an immune drug with chemo, then had surgery. Lab checks of the removed tissue found no live cancer left at all. Six months on, scans showed no return or spread, and the patient had no side effects from the care. The authors say the path may cure some such cases, but call for planned trials.
Catalog record
| CREATOR | Ting Mei, Ting Wang, Chuanfen Lei, Dan Jiang, Qinghua Zhou |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |